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A  number  of recent experiments, both  in  vivo and  in vitro, have suggested 
that  macrophages  play  a  significant  role  in  the  immunologic  responses  of 
lymphocytes of both  the T  (thymus processed)  and B  (nonthymus  processed) 
classes to antigen? 
Three cells, macrophages ("adherent cells") together with T  and B  lymphocytes, 
are required for the antibody response to certain antigens in intact animals (1). Si~:qi- 
larly, in a variety of in vitro systems involving antibody responses to such antigens as 
sheep erythrocytes but not,  for example, to polymerized flagellin, three cells are re- 
quired (2-9). An early interpretation of this finding was that cell cluster formation, 
perhaps providing a  means of antigen presentation, was the essential element in the 
reaction (2,  10,  11).  More recent work,  however,  has shown  that soluble factors re- 
leased by the participating macrophages could be substituted for intact macrophages 
in these systems (5,  12,  13).  Similarly, for the mitotic response of sensitized lympho- 
cytes to specific antigen (14,  15) or of unsensitlzed Iymphocytes to allogeneic cells (16), 
macrophages are  essential but  may  be  replaced by  the  soluble factors which  they 
release (17,  18).  With nonspecific mitogens such as phytohcmagglutinin (PHA), the 
response of thymocytes or "purified" lymphocytes may also be enhanced by the pres- 
ence of cells from peritoneal exudates, bone marrow, spleen, or indeed xenogeneic blood 
leukocytes (19-23). Adherent cells are identified as the active participant in some of 
these experiments (20, 22, 23), but soluble mediators have not thus far been described. 
Macropbages also play a role in the action of many adjuvants (24-26). Here a recruit- 
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ment and mitotic response  of T  cells are observed elements of the adjuvant effect in 
vivo (27-28),2 and the expression of adjuvancy requires the presence of T  cells (28, 29). 
Here, again it is not clear whether a  soluble mediator plays a  role. Hanna et al., (30) 
have suggested that the effective microenvironment provided by tissue macrophages is 
a principal determinant of immune responsiveness and may dwindle with age. 
In  the present  series  of papers  we present  a  detailed  report  of experiments, 
described  elsewhere  in  preliminary  form  (31),  which  show  that  macrophages 
release one or more mitogenic substances.  These act on T  lymphocytes,  greatly 
potentiating  their response  to standard  mitogens  such  as phytohemagglutinin, 
but  do  not  stimulate  B  cells  in  the  absence  of  T  ceils.  Their  production  is 
markedly  enhanced  by  agents  such  as  endotoxin.  Data  concerning  the nature 
of the target cell are given in the present paper. Our study of the cell population 
responsible for release of potentiating  factors  and  preliminary characterization 
of the factors are described  in subsequent  publications  (32).3 
Materials and Methods 
Animals.--Mice  were  obtained  from  the  Jackson  Memorial  Laboratory,  Bar  Harbor, 
Maine. CBA/J mice of both sexes,  6-12 wk old, were used in all experiments except that in 
which cells of mice of several strains  were compared.  Human  peripheral lymphocytes were 
obtained by bleeding colleagues in the laboratory. 
X-Ray.--A Siemens Stabilipan 250 kv machine (Siemens Corp,  Iselin, N.J.)  was used  to 
deliver 850 R  (85  R/min)  to mice in a  special rotating Lucite holder at a  target distance of 
70 cm. These were reconstituted by injection of 5-8  ;<  107 syngeneic thymus cells (XT)  the 
same day, and used 4-7 days after treatment. 
Cell Suspensions.--Mouse cell suspensions  were prepared  (31, 33) by teasing the lymphoid 
tissues  with  needles,  allowing  clumps  to  settle,  and  washing.  The  preparation  of  human 
peripheral  blood  lymphocytes  (PBL)  is  described  in  reference 31.  All manipulations  were 
carried out in minimal essential medium  (MEM-S, with 1-glutamine and antibiotics, Micro- 
biological Associates,  Inc.,  Bethesda,  Md.)  with  8%  pooled  normal  human  serum  added. 
Cell Separation.--Discontinuous bovine serum albumin  (BSA)  density gradients (34) were 
used to separate thymocytes into four bands, designated A, B, C, and D  (from least to most 
dense)  plus a pellet, P. As in earlier work (35, 36), larger cells were found almost exclusively 
in A, B, and C, and macrophages in A and  B. For removal of adherent cells (2, 6),  1-ml all 
quots of cell suspension,  containing l0  T cells in MEM with 10% normal human serum or fetal 
calf serum (Grand Island Biological Co., Grand Island, N.Y.), were incubated in Petri dishes 
(No.  3002,  Falcon Plastics,  Div.  B-D Laboratories,  Inc.,  Los Angeles,  Calif.)  for 40  min, 
and  the  nonattached  cells  separated.  The  process  was  repeated  twice more,  and  the  final 
suspension  of nonadherent cells was used for culture. Purified human lymphocytes were ob- 
tained as described in references 14 and 37.  About 4  X  107  leukocytes in MEM with 10% 
human  serum were incubated in a  Pasteur pipette  (15 cm)  with washed  nylon fibers for 30 
min at  37°C,  and  nonattached  cells were washed  out with  the same medium.  Human  ad- 
herent cells were prepared  (16) by incubating PBL  in MEM with 30°70 autologous human 
2 Spiesel,  S. Z,, R. K. Gershon, and B. H. Waksman.  Adjuvant effects on mouse  thymus- 
derived cells. I. A survey of various classes  of adjuvants. Manuscript in preparation. 
3 Gery, I., and R. E. Handschumacher. Potentiation of lymphocyte responses  to mitogens. 
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serum in Petri dishes for 4 hr, and decanting the nonadherent  cells. The attached cells were 
washed three times with MEM plus 10% human serum before incubation. 
Tissue Culture.--The  materials  employed and  culture  techniques,  as  well as  the use  of 
scintillation counting to measure thymidine-aH incorparation, are described in detail in refer- 
ences 31 and 33. Mouse cultures contained 5 X  10 ~ thymus or 2 X  10 ~ spleen or lymph node 
cells  in  1.0 ml of medium.  Different numbers  of human  cells were employed. All were cul- 
tured in 5% CO2 and  harvested at  72  hr; unless  other~ise  indicated,  thymidine-:~H(T-:;H) 
was given as a  1.0/*(7i pulse during the last 24 hr of incubation. Data are reported as uncor- 
rected counts per minute and  alwa3 s represent  the average of values ohtained in duplicate 
tubes.  1  #1  of  phytohemagglutinin-P  (PHA;  Difco  Laboratories,  Detroit,  Mich.),  3.0  or 
6.0/zg of concanavalin A  (Con  A; Nutritional Biochemicals Corporation, Cleveland, Ohio), 
and 100 #g lipopolysaccharide W from Escherichia coil strain 055 :B5 (LPS ; I)ifco Laboratories) 
were routinely used as mitogens (31, 33). 
Supernalanls.--Human  leukocytes  or  mouse  (syngeneic)  lymphoid  cells  (1.5  X  10 a or 
4  X  10 ~ cells, repectively, in 2.0 ml of medium) were cultured 24 hr without stimulation or 
in the presence of PHA or LPS. Human adherent cells (from  5 X  10 v PBL) were incubated 
in 5 ml of MEM with 20% human serum without mitogen for 48 hr.  All supernatants  (SUP) 
were cleared by centrifuging at 1000 rpm for 10 rain and again at  1800 rpm for 30 rain  and 
TABLE  I 
Effects of Human SUP on the Response to PHA o/Lymphocyles from Various Mouse Lymphoid 
Organs 
Stimulant  Thymus  Lymph nodes  Normal spleen  XT spleen 
None  87*  474  1,504  41 
PHA  337  39,189  34,491  1,522 
PHA +  SUP  21,237  41,544  32,291  10,354 
*  T-aH incorporation (counts perminute). 
were stored at -20°C for up to 2 months hefore being used.  SUP was added at various dilu- 
tions to  mouse cell cultures.  When  not otherwise indicated,  SUP was  produced with  LPS. 
RESULTS 
Effect of Humata SUP  on  Mouse Lymphoid  Cell Responses.--Supernatants, 
prepared  by incubating  human  peripheral  blood 13mphocytes  with LPS  for 24 
hr,  markedly  increase  the  mitotic  response  of  adult  CBA  mouse  thymocytes 
cultured  with  PHA  but not  the  response  of lymph  node  or spleen  cells  (Table 
I).  Spleen  cells  of nfice  harvested  5-7  days  after  whole  body  irradiation  and 
reconstitution  with  syngeneic  thymocytes  (XT  cells)  responded  to  SUP  and 
PHA  in a  manner intermediate between thymocytes and spleen cells (Table I). 
Similar  results  are  obtained  in  experiments  with  human  SUP  prepared  with 
PHA  rather  than  LPS  (31,  32)  and  with SUP prepared  from syngeneic mouse 
spleen  or bone  marrow  (see  below).  The  possibility  that  mitogen  carried  over 
from  the  donor  cell  culture  may  be  responsible  for  the  potentiating  effect  of 
SUP is ruled out by the demonstration  of a similar effect with SUP from human 
adherent  cells incubated  without  stimulant  (Table II). Such  SUP is mitogenic I.  GERY,  R.  K.  GERSHON~  AND  B.  H.  WAKSMAN  131 
alone and increases the response to either PHA or a  suboptimal (unpublished 
data) concentration of Con A but does not affect the response to LPS. 
Kinetics  of  Mouse  Thymocyte  Response  to  Human  or  Mouse  (Syngeneic) 
SUP  and  PHA.--Thymidine-3H  uptake  values  in  thymocyte  cultures  har- 
TABLE  II 
Potentiation of Thymus Cell Responses to Various Mitogens by SUP from Unstimulated Human 
Adherent Cell Culture 
Mitogen* 
T-3H  uptake  (cpm) 
Without SUP  With SUP 
None  104  5,911 
PHA  879  27,613 
LPS  353  7,837 
Con A  9399  23,642 
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Fro.  1.  Thymidine-3H uptake by mouse thymocytes, cultured  for different periods in 
the presence or absence of SUP derived from human PBL (left) or from syngeneic mouse cells 
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vested after various intervals (Fig. 1)  show that spontaneous DNA synthesis 
has largely ceased by the third day and that there is relatively little increase 
in uptake in stimulated cultures after the third day. SUP prepared from syn- 
geneic mouse spleen or bone marrow by incubation with LPS  was  almost as 
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stimulated human cells. In each case,  the SUP itself showed mitogenic activity 
in the absence of PHA, also with a maximal response by the third day. 
Responsiveness  of  Lymphocyles  from  Different  Mouse  Strains  lo  Human 
SUP and Milogens.--Mice  of the four strains  examined  in  the present  study 
showed  significant  differences  in  lymphocyte reactivity  toward  human  SUP 
produced with  LPS  (Tables  II[ and  IV).  SUP  itself serves  as  a  mitogen for 
thymocytes in each case (much better, in fact, than PHA) and appeared to act 
synergistically with  PHA in  CBA,  NZB,  and  SJL mice.  A  synergistic  effect 
with Con A at the concentration used here (6 /~g/ml)  was seen only with AKR 
and  C57BL  thymocytes which  reacted  less  well  to  the  mitogen  alone  than 
thymocyes of the other strains. With SUP q- LPS, the response was no greater 
than with SUP alone,  and it is probable, as shown in the next paper, that the 
TABLE  III 
1,Zffect of Human SUP on Responses of Thymus Cells .b'om  Various Mouse Sh'alns to Different 
M itogens 
CBA/J  AKR/J  SJL/J  C57BL/6J  NZB/J*  Mouse ~train 
Stimulant 
None  135  99  452  87  24 
PHA  843  572  6,208  516  723 
LPS  958  697  1,348  847  183 
Con A;~  143,285  92,148  120,606  76,470  21,794 
SUP§  17,453  14,090  12,806  11,881  2,531 
SUP ~-  PHA  60,568  19,729  44,205  10,254  5,971 
SUP -F LPS  13,945  11,107  10,681  10,544  -- 
SUP +  Con A:~  156,579  134,490  108,633  136,354  -- 
* NZB mice were studied in a separate experiment. 
++ Con A, 6.0/.tg/culture. 
§ SUP, human PBL, stimulated with LPS (1:2). 
response seen  with LPS alone was due to the formation of SUP from thymus 
macrophages  (32).  Essentially  similar  results  were  obtained  in  other  experi- 
ments  making use  of SUP from unstimulated  PBL or PBL exposed to PHA. 
Human SUP was highly mitogenic for spleen  cells, often more so than PHA 
(Table IV), but showed no synergy with PHA or Con A on cells of any strain 
tested.  Indeed,  an  inhibition  of the mitotic response was  apparent  in  several 
instances. 
Responsiveness of  Thymocyle Subpopulalions  to  SUP  -k  Milogens.--When 
normal CBA thymocytes were separated on discontinuous BSA gradients,  the 
lightest  cells,  in  bands  A  and  B,  showed  active spontaneous  DNA svnthesis 
continuing on  the  third  day of culture  (Table  V).  These  cells,  together with 
those in band C, were responsive to PHA, as reported in earlier work (35, 36). 
However, thev were much more stimulated by SUP and still  more by SUP -k 
PHA. Yet  the)-  did  not,  even with  the latter,  reach  the intensity of response I.  GERY,  R.  K.  GERSHON,  AND  B.  H.  WAKSMAN  133 
"FABLE IV 
Ed~ect of Human SUP on Responses  of Spleen  Cells from  Various  Mouse Strains  to Different 
Milogens 
Mouse strain  CBA/J  AKR/J  SJL/J  C57BL/6J  NZB/J* 
Stimulant 
None  1,797  720  1,162  540  381 
PHA  51,157  30,647  57,120  26,688  8,367 
LPS  89,998  79,826  35,384  28,471  16,414 
Con A~  163,520  133,109  162,844  101,485  73,269 
SUP§  70,040  53,060  28,854  28,953  6,854 
SUP -k PHA  57,354  44,942  51,801  40,336  14,335 
SUP+ LPS  79,475  77,519  41,370  43,885  -- 
SUP q- Con A  133,149  119,034  141,773  101,365  -- 
* :~ § As in Table III. 
TABLE  V 
Response  qf Mouse Thymocyle  Subpopulations  to Milogens  and  Human SUP 
Experiment  Stimulant*  Original 
Fraction 
A+B  C  D  P 
I.  ~  q[cells  recovered  3.2  21.0  46.0  29.8 
None  44  2,661  181  13  68 
PHA  794  29,916  4,198  91  62 
SUP-2  13,085  50,796  19,882  2,630  375 
SUP-2+ PHA  19,905  68,296  77,132  5,966  852 
Con A  49,195  176,245  177,043  1,352  58 
II.  % of cells recovered  1.7  15.1  39.7  43.5 
None  40  1,192  47  16  10 
PHA  208  22,247  1,038  49  19 
SUP-2  22,810  35,098  11,923  367 
SUP-2 -F PHA  24,437  57,151  56,161  9,101  659 
SUP-I  54  135  11 
SUP-1 q- "PHA  3,474  27,214  366 
*  SUP-1 was obtained from unstimulated human PBL; SUP-2 was 
stimulated PBL. The SUP preparation used in Exp. I was diluted 1:4; 
undiluted. Con A in Exp. I was used in a dose of 15/zg/culture. 
obtained from PHA- 
those in Exp. II were 
attained with Con A. The denser small cells in band D  and the pellet P, which 
made up  four-fifths of  the total  cells  recovered  showed  neither  spontaneous 
DNA synthesis nor responsiveness to PHA. Yet these cells responded signifi- 
cantly to SUP or the combination of SUP and PHA, the response being greater 
than that elicited with Con A. In this experiment, SUP prepared from unstimu- 
lated PBL showed  no mitogenic activity at the concentration tested,  yet po- 
tentiated the response to PHA markedly. 
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cells, from which adherent cells were removed, required SUP for the expression 
of a PHA response at low cell concentrations (Table VI). At high cell concentra- 
tions,  SUP produced  a  marked  increase in  the response over  that given with 
PHA  alone. The  response of the nonadherent  cells to PHA  alone was greater 
than  that  of unpurified spleen cells, perhaps because of a  relative increase in 
the proportion of T  cells (see reference 14). 
Responsiveness of Purified Human Lymphocyles 1o SUP +  PHA .--It proved 
quite easy to demonstrate a potentiating effect of human SUP on the response 
of highly purified human peripheral blood lymphocytes to PHA when the con- 
TABLE VI 
Role of Potentiating Factors in the Response of Mouse ,Spleen Cells to PHA 
Experiment  Cells/culture X 10  a  SUP  PHA 
I  1000 
50 
II  400 
40 
T-aft uptake 
Original  Nonadherent 
-  -  227  122 
-  q-  14,815  38,841 
q-  -  6,413  7,163 
+  q-  23,886  63,131 
-  -  9  7 
--  q-  9  122 
+  --  44  21 
q-  -}-  69  1,690 
-  --  33  13 
--  +  3,165  7,469 
-+-  --  1,478  411 
+  +  10,465  15,952 
--  --  11  10 
--  +  145  233 
+  --  29  7 
+  +  274  1,167 
centration of cultured cells was lowered sufficiently (Table VII). The effect was 
not seen with unpurified cells and SUP by itself was  not  stimulatory. 
DISCUSSION 
The  observations reported here  establish  that  the proliferative response  of 
T  lymphocytes to nonspecific mitogens is enhanced by soluble factors released 
by  other  lymphoid cells. In  the  following paper,  we  show  that  macrophages 
are the probable source of such factors and  that  their production is markedly 
enhanced  by stinlulants like LPS.  This finding  extends  the  work  of Dutton, 
Shortman,  Bach,  and others demonstrating the participation of similar factors 
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for  the  role  of  the  macrophage  in  lymphoid  cell  interaction  in  responses  to 
both antigen and nonspecific agencies (25, 38). We propose the term "lympho- 
cyte-activating factor" or LAF  for the potentiating activity in question, recog- 
nizing  that  LAF  may  prove  to  be  heterogeneous.  4  Preliminary fractionation 
studies  suggest, 3 however,  that  it is a  single substance.  This paper  provides  a 
simple, reproducible,  and highly sensitive method for its assay. 
TABLE  VII 
Effects  of Human SUP on Reactions  to PHA of Human Leukocytes,  Before and After Column 
Purification 
Experiment  Cells/culture  )< l0  S  SUP*  PHA 
T 3H uptake (cpm) 
Unpurified  Column  purified 
I  500 
II 
--  --  49  38 
--  +  15,899  7,859 
+  --  44  65 
+  +  7,360  22,527 
40  --  --  33  37 
--  +  219  392 
+  --  33  45 
+  +  145  2,036 
400  --  --  87  41 
--  +  32,164  42,287 
+  --  63  174 
+  +  25,979  42,984 
80  --  --  14  25 
--  +  7,036  14,824 
+  --  27  40 
+  +  4,823  16,758 
16  --  --  11  15 
--  +  215  416 
+  -  25  22 
+  +  211  2,983 
* SUP, human PBL, stimulated with LPS (1:4). 
The  principal  and perhaps  only  target of LAF  appears  to be the central  or 
peripheral  T  cell,  since  it  acts  on  thymocytes  and  on  spleen  cells  of  lethally 
irradiated  mice  reconstituted  with  thymus  cells,  both  preparations  largely 
devoid  of  B  lymphocytes.  LAF  was  active  on  preparations  freed  of  macro- 
4 This term was proposed  2  yr  ago  on hypothetical grounds by B.  A.  Askonas and L. 
Jaro~kovA (1970.  In Developmental Aspects of Antibody Formation. J. ~terzl and I. P, iha, 
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phages  by  adherence  to  plastic  or  nylon  fibers.  It  potentiated  responses  to 
PHA  and  to  suboptimal  concentrations  of  soluble  Con  A,  mitogens  which 
stimulate T  lymphocytes exclusively (,39-43).  The failure of PHA to stimulate 
spleen  cells of thvmectomized XBM mice,  even  a  month  after reconstitution 
(33), showed that LAF and PHA are not active on  B  lymphocytes. Our SUP 
preparations did  not  potentiate  the  mitotic  response  of spleen  cells  to LPS, 
which stimulates mitosis only in B  cells in the mouse (3.3). 
The data  show  an  apparent  heterogeneity  in  responses  of T  cells  to LAF 
and to PHA and Con A. In part this depends on the relative numbers of macro- 
phages  in  the  preparations  tested  and  their  consequent  ability  to  produce 
endogenous LAF.  Thus  a  potentiating  effect was  difficult  to demonstrate  in 
whole preparations of human  PBL  or mouse spleen,  in contrast with  thxmo- 
cytes  or  with  peripheral  cell  preparations  after  removal  of  adherent  cells. 
Part of the difference in the PHA responses of different thymocyte subpopula- 
tions obtained on BSA gradients is attributable to the presence of macrophages 
in A and B and their absence in C, D, and P  (36). There is also a heterogeneity 
of the target lymphocytes themselves, however. Within  the thymus, there are 
clearly cells which  respond  to active SUP but not  to PHA, and  others which 
respond only to SUP +  PHA. While the response to Con A by thymocytes in 
the A, B, and C fractions was always greater than the maximum attained with 
SUP +  PHA, cells in D  and P  were stimulated more by SUP alone or SUP + 
PHA than by" Con A. Similarly peripheral T  cells,  as shown by the results with 
nonadherent mouse spleen cells  and column-purified PBL,  show heterogeneity 
in  that  some respond  to  SUP  or  PHA  while  others  appear  to  require  both. 
These differences  may  reflect  differences  in  the  number  of receptor  sites  for 
particular  stimulants  on  individual  cells.  They are  not  related  in  any simple 
way to stages of maturation of cells within the thymus nor, in the present state 
of our knowledge, to the postulated subpopulations, T1 and T2, of the periph- 
eral T-cell pool (44). The differences in response of thymocytes and spleen cells 
among several mouse strains tested reflect the type of heterogeneity" discussed 
here,  but  may  also  depend  on  the  relative  numbers  of macrophages  in  the 
different cell  suspensions (see reference 32). 
The  data  suggesting  heterogeneity  complement  our  earlier  studies  of  im- 
munocompetence in  different  subpopulations  of thvmocvtes  (36,  45),  as  well 
as  those  of other  workers  (46-53).  In  a  number  of species  (rat,  mouse,  pig, 
chicken),  the  usual  parameters  of  T-cell  immunocompetence,  among  them 
ability  to  recirculate,  to  react  against  PHA  or  allogeneic  cells,  to produce  a 
graft-versus-host  reaction, or to cooperate with B cells in an antibody response, 
are found in a minor subpopulation (less than 10% of the total) of thymocytes, 
larger and less dense than the others. After separation on discontinuous density 
gradients  (36,  53),  the smallest and  densest  thymocytes, in  band  D  and  the 
pellet, which  make up three-quarters  to four-fifths of the total  collected from 
the  gradient,  fail to show any of these forms of reactivity. However, a  few of I.  GERY,  R.  K.  GERSHON,  AND  B.  I-I.  WAKSMAN  137 
the cells in D  and possibly in P  can be stimulated by antithymus serum, which 
reacts well with  the  surface of these  cells,  as judged  by immunofluorescence 
and  cytotoxicity (45),  and  a  similar or slightly better response of these  cells 
was stimulated by SUP -Jr PHA. Yet when the numerical representation of the 
different  subpopulations  is  used  to  calculate  the  contribution  of each  to  the 
total T-3H uptake, D  and P  contribute no more than about one-fifth  even  in 
the presence of this maximal stimulation. It is still correct, therefore, to regard 
the preponderance of D  and P  cells as inert. 
In considering the mechanism of action of LAF on T  cells,  two major possi- 
bilities can be envisaged. LAF may act simply as a  mitogen. The synergy of 
LAF with PHA resembles that seen when nonspecific  mitogens, such as PHA, 
anti-lymphocyte serum (ALS), or streptolysin, act together at suboptimal con- 
centrations  or  when  nonspecific  mitogens  act  synergistically  with  specific 
soluble  antigen  (on sensitized  cells)  or  allogeneic cells  (on unsensitized  cells) 
(54, 55). Frequently no mitogenic effect of SUP alone was seen at concentrations 
which  synergized very well  (see,  for example, the data in Tables V, VI,  and 
VII). The characteristic finding that two agents used simultaneously at optimal 
levels may produce a diminished response (54,  55)  is duplicated at a number of 
points in our data, particularly with Con A (e.g., Table IV). This interpretation 
fits well with  Greaves and M611er's suggestion that synergy simply represents 
stimulation  of  an  increased  number  of  receptor  sites  and  that  the  cell  can 
count  (54,  55).  It is  of interest  that  thymocytes maximally stimulated  with 
SUP  -t-  PHA  gave as  great  a  response  as  spleen  cells.  The  possibility  that 
carryover of mitogen,  Con A  in  particular,  from the donor  cultures may ac- 
count  in  part for the  activity of SUP  on  thymocytes is small,  since  Con  A- 
SUP  prepared  with  PBL  or with  mouse  thymus were virtually inactive  and 
since  the  concentration  of Con  A  in  recipient  cultures  (0.75  #g/ml)  was far 
below the mitogenic threshhold? 
An  alternative  hypothesis  is  that LAF  may be  a  nutritional  factor  or  an 
agent which  affects the  metabolic state  of the  cell,  its level of reactivity,  or 
some unidentified property of the cell membrane which affects the numbers or 
reactivity  of  its  receptors  for  mitogens  like  PHA.  Attention  need  only  be 
called  to studies which  show  that insulin  greatly potentiates  chicken  thymo- 
cyte responses to allogeneic cells  (49)  and  that reducing  agents may increase 
the responses of human or rabbit PBL to PHA and ALS by two to three times 
(56). Whitfield and his co!laborators have stressed the effect of cyclic adenosine 
monophosphate  levels  in  potentiating  the  proliferative  responses  of  mouse 
thymocytes to a variety of hormonal or other factors, such as cortisol (at low 
concentration),  parathormone,  vasopressin,  bradykinin,  cyclic  guanidine 
monophosphate,  or even  Mg  ++  (see,  for example, references 57  and  58),  and 
adenyl cyclase triggering appears to be an early event in the response to PHA 
5 Gery, I. Unpublished data. 138  POTENTIATION  OF  T-LYMPHOCYTE  RESPONSES 
(59).  A  relationship  of  this  sort  is  also  implied  by our  results  showing  that 
LAF effects  are  much  more  apparent  at  low concentrations  of peripheral  T 
cells,  which presumably result  in  lower production of "conditioning" factors, 
or at low concentrations of CO+. (20).  A  considerable body of published  work 
had  suggested  that,  while  the  response of peripheral  cells  to antigen  requires 
macrophage mediation,  stimulation  by such mitogens as  PHA does not  (see, 
for example,  references  14  and  16).  However,  Oppenheim  and  his  colleagues 
(14)  have shown a macrophage requirement at low levels  of PHA, i.e.,  with  a 
reduction in the exogenous stimulus applied to the cells. Their finding and ours 
suggest that responses to antigen and to PHA may differ only in a quantitative 
sense. 
SUM  MAR  Y 
Human  and  mouse  lymphoid  cells,  stimulated  by  phytohemagglutinin 
(PHA)  or  lipopolysaccharide W  (LPS),  release  supernatant  factor(s)  which 
are  mitogenic for mouse thymocytes and  which potentiate  their  responses  to 
PHA  or  concanavalin  A  (Con  A).  The  term  LAF  (lymphocyte-activating 
Pactor)  is  proposed  for  this  activity.  LAF not  only enhances  the  mitotic  re- 
sponses of the less dense  thynms sttbpopulations  (A,  B,  and  C)  separable  on 
discontinuous  bovine  sernm  albumin  (BSA)  gradients  but  also  gives  sub- 
stantial  responses in  the otherwise inert cells of the denser fractions D  and P. 
LAF does not exert  a  potentiating sthrmlatorv effect  on the  responses  of un- 
fractionated  mouse  spleen  cells,  but  does  act  synergistically  with  PHA  on 
nonadherent  spleen  cells  and on spleen  cells  of +nice of several  strains 5 days 
after  irradiation  and  injection  of  thvmocvtes.  Similarly  LAF,  which  has  no 
visible  effect  on  unfractionated  human  peripheral  blood  cells,  strongly  po- 
tentiates  the  PHA response  of column-purified  lymphocytes, when  these  are 
cultured at low concentration. We conclude that LAF stimulates both central 
and  peripheral  T  lymphocytes and  enhances  their  responses  to  other stimu- 
lants. 
We gratefully acknowledge the  competent assistance of Wendy C.  Brown in  carrying 
out thtse experiments. 
BIBLIOGRAPHY 
1.  Talmage, D. W., J. Radovich, and H. Hemmingsen. 1969. Cell interaction  in anti+ 
body synthesis. J. Allergy. 43:323. 
2.  Mosier, D. E.  1967. A requirement  for two cell types for antibody,  formation  in 
vilro. Science (Wash. D.C.). 158:157.$. 
3.  Unanue, E. R., B. A. Askonas, and A. C. Allison. 1969. A role of macrophages in 
the stimulation  of immune responses by adjuvants.  J. Immunol.  103:71. 
4.  Shortman,  K.,  E.  Diener,  P.  Russel$, and W. D. Armstrong.  1970. The role of 
nonlymphoid  accessory cells in the  immune response to different  antigens.  J. 
Exp. Med. 131:461. I.  GERY,  R.  K.  GERSHON~  AND  ]3.  H.  WAKSMAN  139 
5.  Shortman,  K.,  and J.  Palmer.  1971. The  requirements  for macrophages in  the 
in vitro immune response. Cell. Immunol. 2:399. 
6.  Tan, T., and J. Gordon.  1971. Participation of three cell  types in the anti-sheep 
red blood cell  response in vitro.  Separation of antigen-reactive  cells  from the 
precursors of antibody-forming cells. J. Exp. Med. 133:520. 
7.  Aaskov, J. G., and W. J. Halliday. 1971. Requirement for lymphocyte-macrophage 
interaction  in  the  response  of mouse  spleen  cultures  to  pneumococcal poly- 
saccharide. Cell. Iramunol. 2:335. 
8.  Haskill, J. S., P. Byrt, and J. Marbrook. 1970. In vitro and in vivo studies of the 
immune response to sheep erythrocytes using partially purified cell preparations. 
J. Exp. Med. 131:57. 
9.  Moore, R. D., and M. D. Schoenberg. 1971, Synthesis of antibody by lymphocytes 
restimulated in vitro with antigen. J. Reticuloendothd.  Soc. 9:254. 
10.  Miller,  H. R. P., and S. Avrameas.  1971. Association between macrophages and 
specific antibody producing cells. Nature (New Biol.) (Loncl.). 29.9:184. 
11.  Schmidtke, J., and E. R. Unanue.  1971. Interaction of macrophages and lympho- 
cytes with surface immunoglobulin. Nature (New Biol.) (Lond.) 233:84. 
12.  Dutton,  R.  W.,  M.  M.  McCarthy,  R.  I.  Mishell,  and  D.  J.  Raidt.  1970.  Cell 
components in the  immune  response.  IV. Relationships  and possible  interac- 
tions. Cell. lmmunol. 1:196. 
13.  Hoffmann, M., and R. W. Dutton. 1971. Immune response restoration with macro- 
phage culture supernatants. Science (Wash. D.C.) 1'/2:1047. 
14.  Oppenheim, J. J., B. G. Leventhal, and E. M. Hersh. 1968. The transformation o[ 
column-purified  lymphocytes with  nonspecific and  specific  antigenic  stimuli. 
J. Immunol. 101:262. 
15.  Schechter,  G.  P.,  and W.  McFarland.  1970. Interaction of lymphocytes and  a 
radioresistant  cell  in PPD-stimulated  human leukocyte cultures.  J. Immunol. 
105:661. 
16.  Alter,  B. J.,  and  F. H.  Bach.  1970. Lymphocyte reactivity  in vitro.  I.  Cellular 
reconstitution of purified lymphocyte response. Cell. lmmunol. 1:207. 
17.  Gordon, J., and L. D. MacLean. 1965. A lymphocyte-stimulating factor produced 
in vitro. Nature (Lond.). 208:795. 
18.  Bach, F. H., B. J. Alter, S. Solliday, D. C. Zoschke, and M. Janis. 1970. Lympho- 
cyte reactivity in vitro. II. Soluble  reconstituting factor permitting response of 
purified lymphocytes. Cell. Immunol. 1:219. 
19.  Iversen, J.-G. 1969. Phytohemagglutinin response of recirculating and non-recircu- 
lating rat lymphocytes. Exp. Cell Res. 56:219. 
20.  Levis, W. R., and J. H. Robbins. 1970. Effect of glass-adherent cells on the blasto- 
genic response of "purified" lymphocytes to phytohemagglutinin. Exp. Cell Res. 
61:153. 
21.  Winkelstein,  A.  1971. Augmentation of PHA responsiveness  in mixed  thymus- 
marrow cultures. J. Immunol.  10'/:195. 
22.  Epstein, L. B., M. J, Cline,  and T. C. Merigan.  1971. The interaction of human 
macrophages and lymphocytes in the phytohemagglutinin-stimulated produc- 
tion of interferon. J. Clin. Invest. 60:744. 
23.  Tridente,  G.,  G.  Biasi, L. Chieco-Bianchi, and L. Fiore-Donati.  1971. Thymus- 
marrow cell interaction in vitro. Enhancing effect of different bone marrow con- 140  POTENTIATION OF  T-LYMPHOCYTE RESPONSES 
stituents on  PHA response  of thymocytes. In Morphological and  Functional 
Aspects of Immunity.  K.  Lindahl-Kiessling, G.  Alm, and  M.  G. Hanna,  Jr., 
editors. Plenum Publishing Corporation, New York. 633. 
24.  Thorbeeke,  G. J., and B. Benacerraf.  1962. The reticulo-endothelial system and 
immunological phenomena. Prog. Allergy. 6:559. 
25.  Schwartz, R. S., R. J. W. Ryder, and A. A. Gottlieb. 1970. Macrophages and anti- 
body synthesis. Prog. Allergy.  14:81. 
26.  Spitznagel, J. K., and A. C. Allison. 1970. Mode of action of adjuvants. Effects on 
antibody responses to  macrophage-associated bovine  serum  albumin.  J.  Im- 
munol. 104:128. 
27.  Dresser, D. W., R. N. Taub, and A. R. Krantz. 1970. The effect of localized injec- 
tion of adjuvant materials on the draining lymph node. Immunology. 18:663. 
28.  Taub, R. N., and R. K. Gershon. 1972. The effect of localized injection of adjuvant 
material on the draining lymph node. III. Thymus dependence. J. Imm~nol. 108: 
377. 
29.  Allison, A.  C.,  and  A.  J.  S.  Davies.  1971. Requirement  of  thymus-dependent 
lymphocytes  for  potentiation  by  adjuvants  of  antibody  formation.  Nature 
(  Lond. ) . 233:330. 
30.  Hanna,  M.  G.,  P.  Nettesheim,  and L.  C.  Peters.  1971. Evidence of functional 
microenvironments in lymphatic tissue response to antigen. Nature (New Biol.) 
(Lond.). 232:204. 
31.  Gery, I.,  R.  K.  Gershon,  and  B.  H.  Waksman.  1971. Potentiation of cultured 
mouse  thymocyte  responses by factors released by  peripheral leukocytes. J. 
Immunol. 107:1778. 
32.  Gery, I., and B. H. Waksman. 1972. Potentiation of the T-lymphocyte response to 
mitogens. II.The cellular source of potentiating mediator(s). J. Exp. Med. 136: 
143. 
33.  Gery, I., J.  Kriiger, and  S. Z.  Spiesel.  1972.  Stimulation of B-lymphocytes by 
endotoxin. Reactions of thymus-derived mice and karyotypic analysis of divid- 
ing cells in mice bearing T6T6 thymus grafts. J. Immunol.  108:1088. 
34.  Raidt, D. J., R. I. Mishell, and R. W. Dutton. 1968. Cellular events in the immune 
response. Analysis and in vitro response of mouse spleen cell populations sep- 
arated by differential flotation in albumin gradients. J. Exp. Med. 128:681. 
35.  Takiguchi, T., W. H. Adler, and R. T. Smith. 1971. Cellular recognition in vitro by 
mouse lymphocytes. Effects of neonatal thymectomy and thymus graft restora- 
tion on alloantigen and PHA stimulation of whole and gradient-separated sub- 
populations of spleen cells. J. Exp. Med. 133:63. 
36.  Colley, D. G., A. Y. Shih Wu, and B. H. Waksman. 1970. Cellular differentiation 
in the thymus. III. Surface properties of rat thymus and lymph node cells sep- 
arated on density gradients. J. Exp. Med. 132:1107. 
37.  Amos, D. B. 1969. Cytotoxicity testing. Iu Manual of Tissue Typing Techniques. 
Compiled  by  Transplantation  Immunology  Branch  Collaborative  Research, 
NIAID, N1H.  1. 
38.  M611er, G., editor. 1969. Antibody-sensitive cells. Transplant. Rev. 1:3. 
39.  Martial-Lasfargues, C., M. Liacopoulos-Briot, and B. N. Halpern.  1967. Culture 
des leucocytes sanguins de souris in vitro, i:;tude de l'action de la phytoh6mag- I.  GERY,  R.  K.  GERSHON,  AND  B.  H.  WAKSMAN  141 
glutinine  (PHA)  sur les lymphocytes de  souris normales et  thymectomis6es. 
C. R. Soc. Biol. 160:2013. 
40.  Greaves, M.  F., I.  M.  Roitt, and M.  E. Rose.  1968.  Effect of bursectomy and 
thymectomy on the responses of chicken periperal blood lymphocytes to phyto- 
haemagglutinin. Nature (Lond.).  220:293. 
41.  Doenhoff, M. J., A. J. S. Davies, E. Leuchars, and V. Wallis. 1970. The thymus 
and circulating lymphocytes of mice. Proc. R. Soc. Lond. B Biol. Sci. 176:69. 
42.  Stobo, J. D., A. S. Rosenthal, and W. E. Paul. 1972. Functional heterogeneity of 
routine lymphoid cells. I. Responsiveness to and surface binding of concanavalin 
A and phytohemagglutinin. J. Immunol. 108:1. 
43.  Andersson, J., G. MSller, and O. SjSberg. 1972. Selective induction of DNA syn- 
thesis in T and B lymphocytes. Cell. Immunol. In press. 
44.  Raft, M. C., and H. I. Cantor. 1971. Subpopulations of thymus cells and thymus- 
derived lymphocytes. In Progress in Immunology. D. B. Amos, editor. Academic 
Press, Inc., New York. 83. 
45.  Shih Wu, A. Y., and B. H. Waksman. 1972. Cellular differentiation in the thymus. 
IV. Response of rat thymic subpopulations to anti-thymus serum and other non- 
specific mitogens. Cell. Immunol. 3:516. 
46.  Rieke, W. O., and M. R. Schwarz. 1964. The culture and karyotype of rat lympho- 
cytes stimulated with phytohemagglutinin. A nat. Rec. 150:383. 
47.  Schwarz, M. R., and W. O. Rieke. 1966. The effect of phytohemagglutinin on rat 
thymus cells in vitro. Anat. Rec. 155:493. 
48.  Weber, W. T. 1966. The in vitro response of thymic lymphocytes of the pig to phy- 
tohemagglutinin. J. Cell Physiol.  67:285. 
49.  Weber, W. T.  1970. Qualitative and quantitative studies on mixed homologous 
chicken thymus cell cultures. Clin. Exp. Immunol. 6:919. 
50.  Blomgren, H., and B. Andersson. 1969. Evidence for a small pool of immunocom- 
petent cells in the mouse thymus. Exp. Cell Res. 57:185. 
51.  Andersson, B., and H. Blomgren. 1970. Evidence for a small pool of immunocom- 
petent cells in the mouse  thymus. Its role in the humoral antibody response 
against sheep  erythrocytes, bovine  serum  albumin,  ovalbumin and  the  NIP 
determinant. Cell. Immunol. 1:362. 
52.  Leckband, E., and E. A. Boyse. 1971. Immunocompetent cells among mouse thy- 
mocytes: a minor population. Science (Wash. D.C.). 172:1258. 
53.  Takiguchi, T., W. H. Adler, and R. T. Smith. 1971. Identification of mouse thymus 
antigen recognition function in a minor, low density, low-0 cell subpopulation. 
Ceil. Immunol. 2:373. 
54.  Greaves, M. F., I. M. Roitt, R. Zamir, and R. B. A. Carnaghan.  1967. Effect of 
anti-lymphocyte serum on responses of human peripheral blood lymphocytes to 
specific and nonspecific stimulants in vitro. Lancet. 2:1317. 
55.  MSller, G. 1970. Induction of DNA synthesis in human lymphocytes. Interaction 
between non-specific mitogens and antigens. Immunology. 19:583. 
56.  Fanger, M. W., D. A. Hart, J. V. Wells, and A. Nisonoff.  1970. Enhancement by 
reducing agents of the transformation of human  and rabbit peripheral lympho- 
cytes. J. Immunol. 105:1043. 
57.  Whitfield, J. F., J. P. MacManus, and R. H. Rixon. 1970. The possible mediation 142  POTENTIATION OF  T-LYMPHOCYTE  RESPONSES 
by cyclic AMP of parathyroid hormone-induced  stimulation of mitotic activity 
and deoxyribonucleic  acid synthesis in rat thymic lymphocytes. J. Cell. Physiol. 
75:213. 
58.  Whitfield,  J. F., J. P. MacManus, and D. J. Gillan.  1970. The possible mediation 
by cyclic AMP of the stimulation of thymocyte proliferation by vasopressin and 
the inhibition of this mitogenic action by thyrocalcitonin. J. Cell. Physiol. 76:65. 
59.  Parker, C. W., J. W. Smith, and A. L. Steiner.  1971. Early effects of phytohemag- 
glutinin  (PHA)  on lymphocyte cyclic  AMP  levels.  Int.  Arch.  Allergy  Appl. 
Immunol. 41:40. 